Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Sudan

Sudan

The Treatment of Cardiovascular Diseases market in Sudan is projected to witness a significant increase in revenue, reaching US$59.80m by the year 2024.
This is expected to be driven by an annual growth rate of 0.44%, leading to a market volume of US$61.14m by 2029.
In comparison to other countries, United States is predicted to generate the highest revenue in this market, amounting to US$136.00bn in 2024.
Sudan's treatment of cardiovascular diseases is hindered by limited access to specialized healthcare facilities and a lack of awareness among the population.

Key regions: Germany, France, Japan, Europe, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.